A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 2 STUDY OF GANITUMAB OR RILOTUMUMAB WITH PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (SCLC)
Bonnie S. Glisson, Andrzej Każarnowicz, Kristiaan Nackaerts et al. · Journal of Thoracic Oncology · 2013
Cited by 4 works.